Skip to content

Clinical trials

Phase 1/2 Esophageal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Country / region: China Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20142
20152
20161
20171
20184
20193
20203
20212
20223
20234
20245
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Unknown status12
Completed6
Active, not recruiting2
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Chinese Academy of Medical Sciences2
Chongqing Precision Biotech Co., Ltd2
Essen Biotech2
Shenzhen BinDeBio Ltd.2
Affiliated Hospital to Academy of Military Medical Sciences1
Amgen1
Anhui Provincial Hospital1
Beijing Friendship Hospital1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms36
Stomach Neoplasms9
Pancreatic Neoplasms7
Breast Neoplasms5
Lung Neoplasms5
Colonic Neoplasms4
Colorectal Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Carcinoma, Hepatocellular3
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.